Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)

China flag China · Delayed Price · Currency is CNY
15.64
-0.09 (-0.57%)
Apr 29, 2026, 3:04 PM CST
Market Cap5.93B -19.4%
Revenue (ttm)2.77B -12.6%
Net Income66.93M -55.0%
EPS0.18 -53.3%
Shares Out379.33M
PE Ratio85.80
Forward PEn/a
Dividend0.25 (1.59%)
Ex-Dividend Daten/a
Volume9,108,300
Average Volume14,187,875
Open16.05
Previous Close15.73
Day's Range15.51 - 16.05
52-Week Range13.45 - 22.47
Beta0.51
RSI54.44
Earnings DateAug 21, 2026

About SHE:300233

Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin pharmaceutical intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. The company was founded in 2004 and is based in Zibo, China. [Read more]

Industry Chemicals
Sector Materials
Founded 2004
Employees 3,515
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300233
Full Company Profile

Financial Performance

In 2025, SHE:300233's revenue was 2.74 billion, a decrease of -18.87% compared to the previous year's 3.37 billion. Earnings were 44.19 million, a decrease of -77.55%.

Financial Statements